Primary Care And Urology Patients With The Male Pelvic Pain Syndrome: Symptoms And Quality Of Life

Turner, Judith A.; Hauge, Stephanie; Korff, Michael Von; Saunders, Kathleen; Lowe, Marc A.; Berger, Richard E.

doi:10.1016/s0022-5347(05)65196-8

Cited by 59 publications

(24 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…21 The QOL of a patient with CP/CPPS is similar to that of a patient with recent myocardial infarction, unstable angina or Crohn's disease. 20 Turner et al, 22 examining men in primary-care settings for QOL, reported that worse QOL was associated with greater pain and urinary symptoms and that pain was more robustly associated with worse QOL than were urinary symptoms. Recently, Tripp et al 23 also reported that pain intensity and urinary symptoms were independent predictors of QOL, with pain intensity the strongest predictor.…”

Section: Discussionmentioning

confidence: 99%

More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study

Paick

2006

Prostate Cancer Prostatic Dis

View full text Add to dashboard Cite

The objective of this study was to evaluate whether extracorporeal magnetic innervation (ExMI) combined with a-blocker therapy is more effective than a-blocker monotherapy for patients with non-inflammatory chronic prostatitis (CP)/chronic pelvic pain syndrome (CPPS), category IIIB. Patients were randomized to either terazosin monotherapy (group 1, n ¼ 21) or terazosin combined with ExMI therapy (group 2, n ¼ 19). Patients in group 2 had 12 treatment sessions of ExMI twice a week during 6 weeks. None of the patients experienced any side effects from treatment. The changes in each domain of the National Institutes of Health (NIH)-Chronic Prostatitis Symptom Index (CPSI) measured on week 6 were not significantly different between the groups. However, the difference (median, 25-75th percentiles) between the two groups in total NIH-CPSI scores was À4 (À11.5, À2) for group 1 and À12 (À17.3, À2.3) for group 2, respectively (P ¼ 0.047). At 6 weeks, 47.6% (10 of 21) of group 1 had a 425% decrease in total NIH-CPSI compared with 78.9% (15 of 19) of group 2 (P ¼ 0.041). Also, more patients in group 2 (78.9%) were rated as responders with a 6-point decrease in NIH-CPSI compared with group 1 (47.6%) (P ¼ 0.041). The early results suggest that ExMI combined with a-blocker therapy has better effect than a-blocker monotherapy for the treatment of CP/CPPS.

show abstract

Section: Discussionmentioning

confidence: 99%

More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study

Paick

2006

Prostate Cancer Prostatic Dis

View full text Add to dashboard Cite

show abstract

“…The present data from tertiary-care patients may not be applicable to experiences of primary-care patients who have shorter symptom duration and fewer medical treatments and diagnostic experiences. 87 However, research suggests that CP/CPPS men in primary-and secondary-care settings can experience persistent and recurrent symptoms as in other chronic pain conditions. 90…”

Section: Study Limitationsmentioning

confidence: 99%

Catastrophizing and Pain-Contingent Rest Predict Patient Adjustment in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Tripp

Nickel

Wang

et al. 2006

The Journal of Pain

115

View full text Add to dashboard Cite

“…Besides, emotional discomfort due to pain and voiding dysfunction also negatively affects the sexual functions. 8,20,21 Prostatic inflammation is a common feature of the adult prostate and is associated with the development and progression of BPH. Asymptomatic inflammatory prostatitis is observed in high amounts in the pathological examination of prostate biopsies or prostate tissues taken after prostatic surgery.…”

Section: Discussionmentioning

confidence: 99%

The effectiveness of sildenafil citrate in patients with erectile dysfunction and lower urinary system symptoms and the significance of asymptomatic inflammatory prostatitis

et al. 2010

View full text Add to dashboard Cite

We evaluated the effectiveness of sildenafil citrate on lower urinary system symptoms (LUTS) by using symptom score scales. We also evaluated whether or not the presence of asymptomatic inflammatory prostatitis had an effect on the alteration in the symptom scores. A total of 36 male patients were included in the study. For all the cases, 'International Prostate Symptom Score' (IPSS), 'National Health Institute Chronic Prostatitis Symptom Index' (NIH-CPSI) and 'International Index of Erectile Function' (IIEF-5) were investigated and the scores were calculated in the first visit. Sildenafil citrate was given for 30 days and at the second visit IPSS, NIH-CPSI and IIEF-5 scores were once more analyzed. Afterwards, the alterations of the scores between visits were statistically compared. Mean age of the 36 cases included in the study was 59.03 ± 1.35. When the alterations in parameters of first visit and second visit were evaluated, we found a statistically significant increase in IIEF-5 and a statistically significant decrease in IPSS, IPSS-QOL (Quality of Life). In addition, when the cases were divided into two groups with and without asymptomatic inflammatory prostatitis, in the cases with asymptomatic inflammatory prostatitis, sildenafil citrate caused improvement only in ED, but had no effect on LUTS. Sildenafil citrate use in cases with LUTS and ED has an improving effect on LUTS as well as ED. However, in cases with asymptomatic inflammatory prostatitis, sildenafil citrate did not lead to an improvement in LUTS.

show abstract

Primary Care And Urology Patients With The Male Pelvic Pain Syndrome: Symptoms And Quality Of Life

Abstract: Pelvic pain is often a persistent, recurrent condition that can have a significant negative impact on quality of life. The average symptom severity in men with pelvic pain in primary care and urology settings is lower than that in tertiary care samples.

Cited by 59 publications

References 14 publications

More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study

More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study

Catastrophizing and Pain-Contingent Rest Predict Patient Adjustment in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome

The effectiveness of sildenafil citrate in patients with erectile dysfunction and lower urinary system symptoms and the significance of asymptomatic inflammatory prostatitis

Contact Info

Product

Resources

About